Skip to main content
Skip to footer
Opens in a new tab
Menu
Who We Are
Our Focus : Mitral Regurgitation
Our TMVR Solution
News
Contact
fr
Press releases
Press releases
Events
Media
HighLife Raises $90+ Million to start its US Pivotal Study and accelerate Commercial Expansion in Europe
HighLife Receives CE Mark Approval for Clarity Valve, the Next-Generation Valve for the HighLife TMVR System
HighLife Receives CE Mark Approval for its TMVR Solution
HighLife granted US FDA Breakthrough Device Designation for its TMVR solution
HighLife Receives ISO 13485 Certification of its Quality Management System
HighLife welcomes Stefan Pilz as new Chief Executive Officer
HighLife Receives IDE Approval to Initiate US Pivotal Clinical Study for treatment of Mitral Regurgitation
HighLife appoints Prof. Stephen Brecker Chief Medical Officer
1
2
3
Top
